| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 09/15/2005 | US20050204422 Using vector transformation to express antisense sequences which suppress phytoene desaturase activity and enhance phytoene concentration in plant |
| 09/15/2005 | US20050204421 Insecticidal protein; increasing resistance of plants to insects |
| 09/15/2005 | US20050204420 Biocidal protein |
| 09/15/2005 | US20050204419 Expression vector coding resistance polypeptide (RB) for use in transformation and geneation of disease resistant tomatoes and potatoes |
| 09/15/2005 | US20050204418 Genetically modified cereal plant having increased energy availability, dereased zein protein expression and enhanced globin protein concentration in grain/seeds |
| 09/15/2005 | US20050204417 Expression vector comprising nucleotide sequences coding novel transferase for generation of plants with increased metabolic flux toward monoterpenes; improving production of essential oils in plants |
| 09/15/2005 | US20050204416 Plant cells having receptor polypeptides |
| 09/15/2005 | US20050204412 Artery- and vein-specific proteins and uses therefor |
| 09/15/2005 | US20050204410 SIRT6 transgenic non-human animals and assay methods |
| 09/15/2005 | US20050204409 Gene for identifying individuals with familial dysautonomia |
| 09/15/2005 | US20050204408 Imparting and/or enhancing glycosaminoglycan binding of water soluble protein via linkage of gene sequences to growth factors, cytokines and/or antibodies |
| 09/15/2005 | US20050204406 Expression vector comprising nucleotide sequences coding blood coagulation factor for use as heterologous gene expression tool; treating blood disorders; bioreactor for producing secreted proteins |
| 09/15/2005 | US20050203283 ISOFORMS OF NUCLEAR RECEPTOR RXR a |
| 09/15/2005 | US20050203282 For screening of agonists and antagonists of receptor which may have advantageous pharmaceutical or diagnostical properties; for identification of patients who may present genetic disorders induced by inactive receptor |
| 09/15/2005 | US20050203281 Generating insoluble matrices comprising immobilized nicotinic acetylcholine receptor (AChR) for use as tool in diagnosing myasthenia gravis; immunodiagnostics |
| 09/15/2005 | US20050203047 Methods for transcription and expression of nucleic acids into organisms; in particular, invention comprises a tRNA vector system to deliver and express short interfering nucleic acid, small interfering (siRNA), micro RNA (miRNA) and antisense (asRNA) into organism with high efficiency; pain treatment |
| 09/15/2005 | US20050203045 Antisense modulation of cellular inhibitor of Apoptosis-2 expression |
| 09/15/2005 | US20050203043 Identification of toxic nucleotide sequences |
| 09/15/2005 | US20050203042 Oligomeric compounds for the modulation of Bcl-2 |
| 09/15/2005 | US20050203041 Antisense compound and method for selectively killing activated T cells |
| 09/15/2005 | US20050203040 siNA molecule comprising a double-stranded structure that down-regulates expression of vascular cell adhesion molecule (VCAM), wherein said siNA molecule does not require the presence of nucleotides having a 2'-hydroxy group within the siNA molecule for mediating RNA interference |
| 09/15/2005 | US20050203036 Compositions and methods for treating hematologic malignancies and multiple drug resistance |
| 09/15/2005 | US20050203033 Identification and characterization of an anthocyanin mutant (ant1) in tomato |
| 09/15/2005 | US20050203026 Rosacea; vascular endothelial growth factor inhibitors; protease inhibitors such as Bowman-Birk Inhibitor, soybean trypsin inhibitor, and Eglin chymotrypsin inhibitor |
| 09/15/2005 | US20050203022 Type II TGF-beta receptor/immunoglobulin constant region fusion proteins |
| 09/15/2005 | US20050203020 Safe drug administration carrier capable of extending the half life of a drug in the blood without the risk of contamination of viruses |
| 09/15/2005 | US20050203012 Human parathyroid hormone modifications, preparation and use |
| 09/15/2005 | US20050203009 Inhibiting VPAC1 (Vasoactive intestinal peptide)-mediated tumorigenesis; inhibits binding of pituitary adenylate cyclase-activating polypeptide (PACAP) to cell membranes |
| 09/15/2005 | US20050203007 Eglin c based drugs for treatment of disease |
| 09/15/2005 | US20050203003 Contulakin-G, analogs thereof and uses therefor |
| 09/15/2005 | US20050202561 Encode antiviral agents that specifically destroy cells infected by human immunodeficiency viruses ("HIV") that produce a protease in such infected cells, antiviral agents are activated by the HIV protease, thereby specifically targeting HIV-infected cells for destruction |
| 09/15/2005 | US20050202560 Simian immunodeficiency retroviral vector for use efficient tool in heterologous gene transfer; improved exogenous gene expression; gene therapy |
| 09/15/2005 | US20050202559 Cancer treatment by metabolic modulations |
| 09/15/2005 | US20050202548 Mammalian enzymatic polypeptide for use as tool in designing drugs which prevent and treat hypercholesterolemia, hyperlipemia, arteriosclerosis, parasitic infection, cell proliferative and vascular diseases |
| 09/15/2005 | US20050202547 Allows the above microorganism to use cyclododecanol and cyclododecanone (12-membered ring compounds) as sole carbon source for growth and energy |
| 09/15/2005 | US20050202545 Methods for producing optically active alpha-hydroxy amides |
| 09/15/2005 | US20050202544 Nucleotide sequences coding benzoic/anthranilic acid regulatory sequences in tandem; gene transfer vector for improving heterologous gene expression |
| 09/15/2005 | US20050202543 Method for producing L-amino acid |
| 09/15/2005 | US20050202541 Three component chimeric antisense oligonucleotides |
| 09/15/2005 | US20050202540 Methods of producing hyaluronic acid using a recombinant hyaluronan synthase gene |
| 09/15/2005 | US20050202536 Nucleotide sequences comprising nucleotide sequences coding immune response modulator; immunotherapeutics; immunodiagnostics |
| 09/15/2005 | US20050202535 Fusion protein comprising bowman-kirk, soybean trypsin and eglin C inhibitors for use in treatment and prevention of inflammatory, arthritic and skin disorders |
| 09/15/2005 | US20050202532 Amino acid sequences for prevention and treatment of cardiovascular disease |
| 09/15/2005 | US20050202530 Enhanced secretion of a polypeptide by a microorganism |
| 09/15/2005 | US20050202529 Humanised antibodies |
| 09/15/2005 | US20050202528 Polypeptides involved in the biosynthesis of spiramycins, nucleotide sequences encoding these polypeptides and applications thereof |
| 09/15/2005 | US20050202527 Fusion polypeptide comprising fibrinopeptide A, serine protease and thrombin-cleavable sequences for use in identifying modulators for prevention and treatment of thrombotic disorders; anticoagulants |
| 09/15/2005 | US20050202520 Has a histidine tag and where the subdomain of the IMPDH polypeptide is modified so that the rate stability of the modified polypeptide is maintained relative to the wild-type IMPDH polypeptide |
| 09/15/2005 | US20050202519 Mutated abl kinase domains |
| 09/15/2005 | US20050202517 Monoclonal antibodies against human apoptosis inhibitory protein NAIP and method for assaying the NAIP |
| 09/15/2005 | US20050202512 Immunoglobulins; libraries; antibodies; complementary determining regions; immunoassay |
| 09/15/2005 | US20050202505 Using oxidoreductase to determine inhibitory effects of 2-acetylbenzofuran; diagnosis and treatment of psychological disorders |
| 09/15/2005 | US20050202502 Oxaloacetate hydrolase deficient fungal host cells |
| 09/15/2005 | US20050202501 Using sequencing by hybridization as tool in detecting variance in genic sequences; identifying restriction fragment length polymorphism and/or single nucleotide polymorphisms |
| 09/15/2005 | US20050202500 Using solid support comprising a multiplicity of immobilized probes as tool to determine transcript abundance in gene expression analysis; diagnosing cell proliferative disorders |
| 09/15/2005 | US20050202498 Linkers that provide enhanced affinity and specificity to chimeric zinc finger proteins |
| 09/15/2005 | US20050202496 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/15/2005 | US20050202490 Methods and compositions for generating and amplifying DNA libraries for sensitive detection and analysis of DNA methylation |
| 09/15/2005 | US20050202489 Method and apparatus for amplifying nucleic acids |
| 09/15/2005 | US20050202487 Methods for isolation of bacteria from biological samples |
| 09/15/2005 | US20050202486 Expression vector comprising nucleotide sequences coding inositol 1,3,4-trisphosphate 5/6-kinase for use in transfomation of plants and enhancement of non-phytate phosphorous production in corn, soy and animal feeds |
| 09/15/2005 | US20050202481 Novel polypeptide ESDN, polynuleotides encoding the polypeptide, and utility of the polypeptide |
| 09/15/2005 | US20050202480 Stabilization of linear double-stranded DNA in the presence of exonucleases |
| 09/15/2005 | US20050202479 Methods and materials relating to insulin growth factor-like (IGFL) polypeptides and polynucleotides |
| 09/15/2005 | US20050202476 Detection of microorganisms |
| 09/15/2005 | US20050202474 Phosphodiesterases |
| 09/15/2005 | US20050202473 Using variation in nucleotide repeat sequences as diagnostic indicators of cell proliferative disorders |
| 09/15/2005 | US20050202472 Using long transient receptor potential channels (LTRPC2) as tools in identifying modulators for intracellular calcium concentration |
| 09/15/2005 | US20050202467 Nucleotide sequences coding serotonin receptor (5-HT1A receptor) for use in identifying modulators for prevntion and treatment of neuropsychiatric disorders |
| 09/15/2005 | US20050202466 Method for sequencing nucleic acid molecules |
| 09/15/2005 | US20050202462 Hepatic modulator for prevention and treatment of hepatic dysfunction, hepatitis and liver cancer |
| 09/15/2005 | US20050202458 Using serial analysis of gene expression (SAGE) to identify tumor specific genes; immuotherapy; tissue targeted therapy |
| 09/15/2005 | US20050202456 Processes for detecting or quantifying analytes of interest |
| 09/15/2005 | US20050202455 Process for producing two or more copies of nucleic acids in a library, and process for detecting or quantifiying more than one nucleic acid in a library |
| 09/15/2005 | US20050202454 "STRAP" and "STEAP"(six transmembrane (epithelial) antigen of the prostate) |
| 09/15/2005 | US20050202453 Using rolling circle amplification (RCA) to replicate plasmid DNA, isolated from yeast , comprising heterologous gene sequences; gene expression analysis; DNA sequencing; yeast two-hybrid analysis |
| 09/15/2005 | US20050202452 Assay determining the activity of an agent to decrease cell division; contacting protein capable of superoxide production with compound of interest and and measuring the ability of the agent to decrease superoxide production, inhibit diaphorase activity or bind the protein |
| 09/15/2005 | US20050202450 Polypeptides stable under hypoxic and nonhypoxic conditions; antihypoxic agents; myocardial necrosis and arrhythmia, strokes, autoimmune deseases, neurodegenerative disorders |
| 09/15/2005 | US20050202443 Type II restriction endonuclease and application thereof |
| 09/15/2005 | US20050202437 Expression vector comprised of lactobacillus and heterologous gene sequences for use as gene therapeutic tools; enhancing expression of exogenous gene sequences |
| 09/15/2005 | US20050202434 Inhibition of metallo-beta-lactamase |
| 09/15/2005 | US20050202432 Plurality of genes differentially expressed in kidney cells after exposure to hormone; identifying agents which enhance calcium uptake in post-menopausal women; diagnosing and treating cardiovascular disorders |
| 09/15/2005 | US20050202430 Nucleotide sequences coding extracellular matrix protein for use in treatment and prevention of cell proliferative disorders; promoting osteogenesis |
| 09/15/2005 | US20050202429 Microcapsules with controlable permeability encapsulating a nucleic acid amplification reaction mixture and their use as reaction compartment for parallels reactions |
| 09/15/2005 | US20050202428 Notch signaling inhibitory RNA sequences for use in treatment and prevention of cell proliferative and developmental disorders |
| 09/15/2005 | US20050202426 Whole cell engineering using real-time metabolic flux analysis |
| 09/15/2005 | US20050202425 expression vector; host cell transformed with gene; culturing cell to produce polypeptide that has an activity of converting a sulfated fucogalactan into a smaller molecule |
| 09/15/2005 | US20050202424 Membrane protein for use as tool in identifying modulators for treatment of phenotype-mediated antibiotic-resistance; microbiocides; bactericides; preventing infection in cystic fibrosis patients |
| 09/15/2005 | US20050202423 Identifying ribonucleic acid binding agents for use in prevention and treatment of human and/or feline immunodeficiency syndrome |
| 09/15/2005 | US20050202413 nucleic acid encoding an immunoreactive peptide not recognized by antibodies which are directed against other herpes-viruses for accurate diagnosis; test kits |
| 09/15/2005 | US20050202408 Chemical screening using a proline-rich nuclear receptor co-regulatory protein/nuclear receptor co-expression system |
| 09/15/2005 | US20050202403 Yeast cells expressing modified G proteins and methods of use therefor |
| 09/15/2005 | US20050202396 Microarray with increased flexibility for use in gene expression analysis |
| 09/15/2005 | US20050202077 Targeted delivery of RNA interference molecules |
| 09/15/2005 | US20050202075 Liposome with an internal compartment; a gene encoding a short hairpin RNA, within the internal compartment of the liposome; receptors targeting agents; conjugation agents connecting targeting agents to the exterior surface of liposome via conjugation agents |
| 09/15/2005 | US20050202048 Chlamydia antigens and vaccine uses of the protein |
| 09/15/2005 | US20050202042 Toxin B repeating units (rBRU) of Clostridium difficile and an antigen of a pathogenic microorganism other than C. difficile; eliciting T-cell dependent and antibody responses |
| 09/15/2005 | US20050202035 Stress protein complex; a grp170 polypeptide and an immunogenic polypeptide; antitumor |
| 09/15/2005 | US20050202026 Introducing into a first plant an expression vector containing a nucleotide sequence encoding the protection protein operably linked to a transcriptional promoter, introducing into a second plant an expression vector, crossing first plant and second plant to produce offspring, selecting transgenic plant |
| 09/15/2005 | US20050202022 Polynucleotides encoding humanized antibodies against human 4-1BB |